Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rub U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD
Nature. 2010 Aug 26;466(7310):1069-75. doi: 10.1038/nature09320. PubMed Article
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rub U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD
Nature. 2010 Aug 26;466(7310):1069-75. doi: 10.1038/nature09320. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 84910 | pcDNA3.2 YFP | expression of YFP in mammalian cells |
| 84911 | pcDNA3.2 TDP-43 YFP | expression of TDP-43 YFP in mammalian cells |
| 84912 | pcDNA3.2 TDP-43 NLS1 YFP | Mammalian expresion of TDP-43 NLS1 YFP |
| 84913 | pcDNA3.2 TDP-43 NLS1, 5F-L YFP | Mammalian expresion of TDP-43 NLS1, 5F-L YFP |
| 84914 | pcDNA3.2 TDP-43 5F-L YFP | Mammalian expresion of TDP-43 5F-L YFP |